Home HCFA TEAM February 15, 2023

Cystic Fibrosis
The most common inherited disease

1 in 2,000-2,500 children are born each year with C.I. A multisystemic disease with a low survival rate, mainly affecting the lungs and pancreas. In Greece more than 500,000 are healthy carriers of the disease, while worldwide Cystic Fibrosis affects more than 88,000 people.

The areas of our actions

Advocating for CF patients & caregivers
Supporting CF community
Supporting CF centers
Access to medicines & treatments
Supporting lung transplants
Informing health professionals
Promotion of research
Collaboration with stakeholders
Prevention & early diagnosis
Public awareness

Prix Galien Greece 2021

We were awarded the Prix Galien Greece 2021 for the start of the early access program to revolutionary treatment for CF patients in Greece.

"Unlimited Breath"

The first national helpline for Cystic Fibrosis in Greece

Our team is here to guide you and answer all your questions about the most common inherited disease.
Call us at 0030-2110137700 every Tuesday: 11.00-15.00 (EEST), Wednesday & Thursday: 15.00-19.00 (EEST) or email us at helpline@cysticfibrosis.gr or chat with us live in the website chatbox and on social media.

"Secret Mission C.F."

The first interactive children’s book for Cystic Fibrosis in Greece

For young and old patients, their caregivers, and anyone who wishes to unravel the mystery of the disease and unlock its secrets.

Carriers of the disease in Greece
0 +
Possibility for a child of 2 carriers to be born with Cystic Fibrosis
0 %
Patients in Greece
0 +
CF gene mutations
0 +
Patients in Europe

Living with Cystic Fibrosis

Patients and their families share their experiences, their concerns, their thoughts and the challenges they face in their life with CF, the good days and the difficult moments.

Are you a Cystic Fibrosis patient, caregiver, relative or friend? You wish to share your story?

Our news

We are members of European Organisations

Our supporters

This website was reconstructed with the support of Vertex Pharmaceuticals and Chiesi Hellas